Tocilizumab Stabilizes Renal Function in Kidney Transplant Recipients with Chronic Active Antibody Mediated Rejection (CAAMR).

被引：0
|
作者：
Patel, S. [1 ]
Mohan, S. [1 ]
Fernandez, H. [1 ]
Batal, I. [1 ]
Ratner, L. [1 ]
Crew, J. [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
205
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [41] Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Raynaud, M.
    Halloran, P.
    Loupy, A.
    Chang, J.
    Reeve, J.
    Yakubu, I.
    Bobba, S.
    Kamal, L.
    Levy, M.
    Bhati, C.
    Kimball, P.
    King, A.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 453 - 453
  • [42] Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
    Cabezas, Lara
    Jouve, Thomas
    Malvezzi, Paolo
    Janbon, Benedicte
    Giovannini, Diane
    Rostaing, Lionel
    Noble, Johan
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Belatacept in Chronic Kidney Disease Stabilizes and Improves Renal Function in Pancreas Transplant Recipients: Intermediate Results
    Chen, J.
    Mujtaba, M.
    Taber, T.
    Yaqub, M.
    Powelson, J.
    Adebiyi, O.
    Fridell, J.
    Sharfuddin, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 352 - 352
  • [44] Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients is Associated with Increased Risk of Urinary Tract Infections and Pneumonia
    Joachim, E.
    Parajuli, S.
    Swanson, K.
    Aziz, F.
    Garg, N.
    Mohamed, M.
    Mandelbrot, D.
    Djamali, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 851 - 851
  • [45] Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
    Aziz, Fahad
    Parajuli, Sandesh
    Jorgenson, Margaret
    Garg, Neetika
    Manchala, Venkata
    Yousif, Elsadiq
    Mandelbrot, Didier
    Hidalgo, Luis
    Mohamed, Maha
    Zhong, Weixiong
    Djamali, Arjang
    [J]. TRANSPLANTATION DIRECT, 2022, 8 (09): : E1360
  • [46] Clinical Outcome of Rituximab and Intravenous Immunoglobulin Combination Therapy in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Ban, Tae Hyun
    Yu, Ji Hyun
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. ANNALS OF TRANSPLANTATION, 2017, 22 : 468 - 474
  • [47] Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
    Nickerson, P.
    Boehmig, G.
    Chadban, S.
    Kumar, D.
    Mannon, R. B.
    Van Gelder, T.
    Adler, S.
    Chong, E.
    Djamali, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 737 - 737
  • [48] Acute antibody-mediated rejection in paediatric renal transplant recipients
    Kranz, Birgitta
    Kelsch, Reinhard
    Kuwertz-Broeking, Eberhard
    Broecker, Verena
    Wolters, Heiner H.
    Konrad, Martin
    [J]. PEDIATRIC NEPHROLOGY, 2011, 26 (07) : 1149 - 1156
  • [49] THE ROLE OF BORTEZOMIB IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH ANTIBODY MEDIATED REJECTION
    Pearl, M.
    Ettenger, R.
    Chambers, E. Tsai
    Nayak, A.
    [J]. PEDIATRIC TRANSPLANTATION, 2015, 19 : 89 - 89
  • [50] Microvascular Inflammation in Renal Transplant Recipients Without Antibody Mediated Rejection
    Chowdhury, Raad
    Saba, Johnny Bu
    Hariharan, Sundaram
    Cherukuri, Aravind
    [J]. TRANSPLANTATION, 2022, 106 (09) : S374 - S374
12345